Lasseck Julia, Schröer Uwe, Koenig Simone, Thanos Solon
Department of Experimental Ophthalmology, School of Medicine, University Eye Hospital Muenster, Domagkstrasse 15, 48149 Muenster, Germany.
Exp Eye Res. 2007 Jul;85(1):90-104. doi: 10.1016/j.exer.2007.03.005. Epub 2007 Mar 24.
This study used organ cultures to examine whether retinal ganglion cells (RGCs) retain their ability to regenerate axons in buphthalmos. A rat mutant with hereditary buphthalmos was used to (1) determine whether the extent of RGC loss corresponds to the severity and duration of elevated intraocular pressure (IOP), (2) examine whether RGCs exposed to an elevated IOP are able to regenerate their axons in a retina culture model, and (3) analyze the proteome of the regenerating retina in order to identify putative regeneration-associated proteins. Retrograde labeling of RGCs revealed a decrease in their numbers in the retinas of buphthalmic eyes that increased with age. Quantification of axons growing out of retinal explants taken at different stages of the disease demonstrated that buphthalmic RGCs possess a remarkable potential to regrow axons. As expected, immunohistochemistry and immunoblotting revealed that elevated IOP was associated with upregulation of certain known proteins, such as growth-associated protein 43, glial fibrillary acidic protein, and endothelin-1. In addition, two-dimensional polyacrylamide gel electrophoresis and mass spectrometry revealed several spots corresponding to proteins that were specifically regulated when buphthalmic RGCs were permitted to regrow their axons. Out of the proteins identified, heat-shock protein (HSP)-60 was constantly expressed during axonal growth at all stages of the disease. Antibodies against HSP-60 reduced axonal growth, indicating the involvement of this protein in regenerative axonal growth. These data are the first to show that diseased retinal neurons can grow their axons, and that HSP-60 supports neuritogenesis. This model may help to elucidate the fundamental mechanisms of optic neuropathy at stages preceding death caused by chronic injury, and aid in the development of neuroprotective strategies.
本研究采用器官培养法,以检验视网膜神经节细胞(RGCs)在牛眼症中是否保留其轴突再生能力。利用一种遗传性牛眼症大鼠突变体来:(1)确定RGCs损失程度是否与眼内压(IOP)升高的严重程度和持续时间相对应;(2)检验在视网膜培养模型中,暴露于升高IOP的RGCs是否能够再生其轴突;(3)分析再生视网膜的蛋白质组,以鉴定假定的再生相关蛋白。RGCs的逆行标记显示,牛眼症眼睛视网膜中RGCs数量减少,且随年龄增长而增加。对取自疾病不同阶段的视网膜外植体长出的轴突进行定量分析表明,牛眼症RGCs具有显著的轴突再生潜力。正如预期的那样,免疫组织化学和免疫印迹显示,IOP升高与某些已知蛋白的上调有关,如生长相关蛋白43、胶质纤维酸性蛋白和内皮素-1。此外,二维聚丙烯酰胺凝胶电泳和质谱分析显示,有几个斑点对应于牛眼症RGCs轴突再生时特异性调节的蛋白质。在鉴定出的蛋白质中,热休克蛋白(HSP)-60在疾病所有阶段的轴突生长过程中持续表达。针对HSP-60的抗体减少了轴突生长,表明该蛋白参与了轴突再生生长。这些数据首次表明,患病的视网膜神经元能够生长其轴突,且HSP-60支持神经突形成。该模型可能有助于阐明慢性损伤导致死亡前阶段视神经病变的基本机制,并有助于制定神经保护策略。